by StepChange Innovations GmbH
Login Status
You are not logged in.

Categories
Newsletter
Receive abstracts of new posts by e-mail
* = required field
Data Privacy

Sponsored Ads

Indian government forces Bayer to accept generic Nexavar competition – FiercePharma

NexavarIndia has invoked its compulsory licensing rules for the first time, allowing the domestic drugmaker Natco Pharma to make and sell a version of Bayer’s cancer drug Nexavar–despite the fact that Nexavar is still on patent.

We think this is quite a significant development. What does it mean for ROI of big pharma companies R&D ? What does it mean for IP integrity for doing business in India ?

Indian government forces Bayer to accept generic Nexavar competition – FiercePharma.

Christian Schumacher

Dr. Christian Schumacher is the founder and managing director of StepChange Innovations GmbH, a technology development and consulting firm based in Germany. He has more than 20 years of experience in the chemical industry with global players such as Hoechst AG and DyStar Textilfarben GmbH as head of R&D, senior regional business manager Asia Pacific, head of e-commerce, head of marketing services, new product development manager and R&D chemist.

More Posts

Follow Me:
LinkedIn

Sponsored Ads
Archives
Disclosure
Legal Disclosure
Data Privacy
Copyright Information: Images: © Fotolia
Calendar
March 2012
M T W T F S S
« Feb   Apr »
 1234
567891011
12131415161718
19202122232425
262728293031  

Copyright © 2013. All Rights Reserved.